Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 13, 2026 12:12 ET | Source: HeroMD

HeroMD 4-MAX Claims Evaluated: Why Men Searching "Most Effective 4-in-1 Erectile Dysfunction Formula" Are Comparing SURGE, PRIME and The HERO System Explained

HeroMD 4-MAX scam or legit? Compounded 4-in-1 sublingual ED formula with 10-min onset and 36-hr window reviewed.
June 13, 2026 12:02 ET | Source: Sentauto Automotive Communication Company

セントオート、「1997年から新時代へ：フリーランダーがランドローバーのDNAを現代的デザインにどう再解釈したか」というニュース記事を掲載

北京発 , June 14, 2026 (GLOBE NEWSWIRE) -- セントオート・オートモーティブ・コミュニケーション・カンパニー (Sentauto Automotive Communication Company) は、「1997年から新時代へ：フリーランダーがランドローバーのDNAを現代的デザインにどう再解釈したか (From 1997 to a New Era: How...
June 13, 2026 11:30 ET | Source: Kessler Topaz Meltzer & Check LLP

NASDAQ: WGS: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against GeneDx Holdings Corp. (WGS)

Did you buy WGS securities between April 16, 2025, and May 4, 2026? Affected WGS Investor Summary Who: GeneDx Holdings Corp. (NASDAQ: WGS)What: Securities fraud class action lawsuit filedClass...
June 13, 2026 11:12 ET | Source: The Rosen Law Firm PA

MANH Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. – MANH

NEW YORK, June 13, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of...
June 13, 2026 11:00 ET | Source: European Academy of Allergy and Clinical Immunology

EAACI 呼吁迈向“零愿景”，打造没有过敏与哮喘负担的未来

苏黎世, June 13, 2026 (GLOBE NEWSWIRE) -- 随着过敏性疾病持续影响全球数亿人口，并给医疗系统带来日益沉重的压力，European Academy of Allergy and Clinical Immunology (EAACI) 呼吁确立一项全新的全球健康愿景——“零愿景”：打造没有过敏与哮喘负担的未来。这一愿景将成为 2026 年 6 月 12 日至...
June 13, 2026 11:00 ET | Source: European Academy of Allergy and Clinical Immunology

EAACI 呼籲推動「零願景」未來，致力消除過敏症與哮喘帶來的健康負擔

蘇黎世, June 13, 2026 (GLOBE NEWSWIRE) -- 隨著過敏疾病持續對全球數以億計人口帶來影響，亦為醫療系統增添壓力，European Academy of Allergy and Clinical Immunology (EAACI) 呼籲在全球健康領域樹立全新目標：實現「零願景」的未來，消除過敏症與哮喘病帶來的健康負擔。這個願景將成為 2026 年 EAACI...
June 13, 2026 11:00 ET | Source: European Academy of Allergy and Clinical Immunology

L’EAACI appelle à une « Vision Zéro » pour un avenir libéré du fardeau des allergies et de l’asthme

ZURICH, 13 juin 2026 (GLOBE NEWSWIRE) -- Alors que les maladies allergiques continuent de toucher des centaines de millions de personnes dans le monde et exercent une pression croissante sur les...
June 13, 2026 11:00 ET | Source: European Academy of Allergy and Clinical Immunology

EAACI fordert eine Zukunft im Sinne von „Vision Zero“, frei von Allergien und Asthma

ZÜRICH, June 13, 2026 (GLOBE NEWSWIRE) -- Da allergische Erkrankungen weiterhin Hunderte Millionen Menschen weltweit betreffen und die Gesundheitssysteme zunehmend belasten, fordert die...
June 13, 2026 11:00 ET | Source: European Academy of Allergy and Clinical Immunology

EAACI קוראת לעתיד "חזון אפס" ללא נטל אלרגיה ואסטמה

ציריך, June 13, 2026 (GLOBE NEWSWIRE) -- בעוד שמחלות אלרגיות ממשיכות להשפיע על מאות מיליוני אנשים ברחבי העולם ולהטיל לחץ גובר על מערכות הבריאות, האקדמיה האירופית לאלרגיה ואימונולוגיה קלינית...
June 13, 2026 11:00 ET | Source: European Academy of Allergy and Clinical Immunology

EAACI Menyerukan Masa Depan "Vision Zero" yang Bebas dari Beban Alergi dan Asma

ZURICH, June 13, 2026 (GLOBE NEWSWIRE) -- Penyakit alergi terus memengaruhi ratusan juta orang di seluruh dunia dan memberikan tekanan yang semakin besar pada sistem layanan kesehatan. Oleh karena...